Skip to content
Subscriber Only

Drugmakers Pledge to Avoid Safety Shortcuts on Covid Vaccine

  • Companies will wait for key data to seek marketing approval
  • Merck, Pfizer, Glaxo say patient safety is “top priority”

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Drugmakers racing to produce Covid-19 vaccines pledged to avoid shortcuts on science as they face pressure to rush a shot to market.